Bain Capital Public Equity Management, LLC - Q3 2014 holdings

$3.9 Billion is the total value of Bain Capital Public Equity Management, LLC's 52 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was - .

 Value Shares↓ Weighting
CTXS NewCITRIX SYS INC$160,964,0002,256,300
+100.0%
4.13%
KMR NewKINDER MORGAN MANAGEMENT LLC$109,834,0001,166,590
+100.0%
2.82%
CMCSA NewCOMCAST CORP NEWcl a$106,823,0001,986,300
+100.0%
2.74%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$97,735,0001,100,000
+100.0%
2.51%
CVLT NewCOMMVAULT SYSTEMS INC$80,867,0001,604,500
+100.0%
2.07%
WFTIQ NewWEATHERFORD INTL PLC$63,452,0003,050,600
+100.0%
1.63%
MNST NewMONSTER BEVERAGE CORP$38,300,000417,800
+100.0%
0.98%
S NewSPRINT CORP$29,424,0004,641,000
+100.0%
0.76%
NewAMETEK INC NEW$24,653,000491,000
+100.0%
0.63%
TDY NewTELEDYNE TECHNOLOGIES INC$24,295,000258,433
+100.0%
0.62%
COMM NewCOMMSCOPE HLDG CO INC$19,893,000832,000
+100.0%
0.51%
KMIWS NewKINDER MORGAN INC DEL*w exp 05/25/201$18,200,0005,000,000
+100.0%
0.47%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Brookside Capital Investors, L.P. #1
  • Brookside Capital Partners Fund, L.P. #2
  • Brookside Capital Trading Fund, L.P. #3
  • Brookside Capital Investors II, L.P. #4
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CITRIX SYS INC18Q3 20186.7%
QUINTILES TRANSNATIO HLDGS I18Q3 20173.5%
AFFIMED N V16Q1 20191.0%
BALL CORP13Q1 20197.2%
RADIUS HEALTH INC13Q2 20178.4%
TRANSDIGM GROUP INC11Q2 201610.1%
ULTA SALON COSMETCS & FRAG I11Q4 20155.4%
VIASAT INC11Q2 20177.5%
AETNA INC NEW11Q2 20174.1%
GODADDY INC10Q1 20195.7%

View Bain Capital Public Equity Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
Bain Capital Public Equity Management, LLC Q3 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Affimed N.V.February 14, 20192,362,8133.8%
IMMUNE DESIGN CORP.February 14, 2019892,0611.8%
REVA Medical, Inc.February 14, 2019296,502,2207.2%
MULESOFT, INCFebruary 14, 20181,404,0251.9%
CONCERT PHARMACEUTICALS, INC.February 28, 20141,147,8336.7%
IDENIX PHARMACEUTICALS INCFebruary 12, 201413,115,8589.8%
NORTHSTAR REALTY FINANCE CORP.February 12, 20147,657,7812.6%
PORTOLA PHARMACEUTICALS INCFebruary 12, 2014400,0001.0%
Dicerna Pharmaceuticals IncFebruary 10, 20141,337,0008.0%
RingCentral IncFebruary 07, 2014471,0735.5%

View Bain Capital Public Equity Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2020-11-16
13F-HR2020-08-14
13F-HR2020-05-15
13F-HR2020-02-14
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
SC 13G/A2019-02-14
SC 13G/A2019-02-14

View Bain Capital Public Equity Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (3899657000.0 != 3899656000.0)

Export Bain Capital Public Equity Management, LLC's holdings